Adverse events5,784

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 5,784

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anaemia	Blood and lymphatic system disorders	Base Study + First Extension: Odanacatib 50 mg OW	477	8,043	552
other	Anaemia	Blood and lymphatic system disorders	Base Study + First Extension: Placebo	500	8,028	583
other	Anaemia	Blood and lymphatic system disorders	Second Extension: Odanacatib 50 mg OW	0	3,144	0
other	Anaemia	Blood and lymphatic system disorders	Second Extension: Odanacatib 50 mg OW (Placebo)	0	2,309	0
other	Cataract	Eye disorders	Base Study + First Extension: Odanacatib 50 mg OW	488	8,043	638
other	Cataract	Eye disorders	Base Study + First Extension: Placebo	492	8,028	652
other	Cataract	Eye disorders	Second Extension: Odanacatib 50 mg OW	0	3,144	0
other	Cataract	Eye disorders	Second Extension: Odanacatib 50 mg OW (Placebo)	0	2,309	0
other	Constipation	Gastrointestinal disorders	Base Study + First Extension: Odanacatib 50 mg OW	492	8,043	547
other	Constipation	Gastrointestinal disorders	Base Study + First Extension: Placebo	504	8,028	552
other	Constipation	Gastrointestinal disorders	Second Extension: Odanacatib 50 mg OW	0	3,144	0
other	Constipation	Gastrointestinal disorders	Second Extension: Odanacatib 50 mg OW (Placebo)	0	2,309	0
other	Diarrhoea	Gastrointestinal disorders	Base Study + First Extension: Odanacatib 50 mg OW	589	8,043	726
other	Diarrhoea	Gastrointestinal disorders	Base Study + First Extension: Placebo	504	8,028	608
other	Diarrhoea	Gastrointestinal disorders	Second Extension: Odanacatib 50 mg OW	0	3,144	0
other	Diarrhoea	Gastrointestinal disorders	Second Extension: Odanacatib 50 mg OW (Placebo)	0	2,309	0
other	Bronchitis	Infections and infestations	Base Study + First Extension: Odanacatib 50 mg OW	450	8,043	591
other	Bronchitis	Infections and infestations	Base Study + First Extension: Placebo	459	8,028	611
other	Bronchitis	Infections and infestations	Second Extension: Odanacatib 50 mg OW	0	3,144	0
other	Bronchitis	Infections and infestations	Second Extension: Odanacatib 50 mg OW (Placebo)	0	2,309	0

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00529373/events

API reference For AI assistants

Adverse events5,784

Sources 3

Read this list from software.